Company Overview
Bio-Images Drug Delivery Ltd is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Friday 06 August 2010, so this is a well established company. Bio-Images Drug Delivery Ltd has been in business for 15 years and 7 months. The accounts status is total exemption full and the accounts are next due on Monday 31 August 2026.
Registered Address

Bio Imaging Unit, Basement Medical Block Within Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameBIO-IMAGES DRUG DELIVERY LTD
Company NumberSC383233
Registered Office AddressBio Imaging Unit, Basement Medical Block Within Glasgow Royal Infirmary
 84 Castle Street
 G4 0SF
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date06/08/2010
Accounting Reference Date Day30
Accounting Reference Date Month11
Accounts Next Due Date31/08/2026
Accounts Last Made Up Date30/11/2024
Accounts Account CategoryTOTAL EXEMPTION FULL
Returns Next Due Date03/09/2016
Returns Last Made Up Date06/08/2015
Previous Company NameChanged Date
BIO-IMAGES GROUP LIMITED19 Mar 2014
ENSCO 335 LIMITED25 Oct 2010
Directors & Members
Show Resigned
Glenn Crocker - Director
(British, 62 years old, born March 1964)
Appointed 24 February 2014
 Active
Laura Gow - Director
(British, 42 years old, born July 1984)
Appointed 22 August 2022
 Active
Joanne Kelley - Director
(British, 67 years old, born October 1959)
Appointed 01 August 2018
 Active
Claire Madden-Smith - Director
(British, 53 years old, born March 1973)
Appointed 01 May 2022
 Active
Howard Stevens - Director
(British, 82 years old, born March 1944)
Appointed 08 April 2011
 Active
Carol Thomson - Director
(British, 52 years old, born July 1974)
Appointed 11 July 2013
 Active
Secretaries
Show Resigned
Other Company Directorships
Glenn Crocker
AESICA FORMULATION DEVELOPMENT LIMITED
ALDERLEY ANALYTICAL LTD
ALDERLEY PARK VENTURES LIMITED
BDD PHARMA LTD
BIOCITY ALDERLEY LIMITED
BIOCITY GROUP LIMITED
BIOCITY INVESTMENTS LIMITED
BIOCITY LIMITED
BIOCITY NOTTINGHAM LIMITED
BIOCITY SCOTLAND LIMITED
BIOHUB AT ALDERLEY LIMITED
BIOHUB LIMITED
DRUG DELIVERY INTERNATIONAL LIMITED
EMB LIMITED
INTELLIGENT OMICS LIMITED
MEDICITY LIMITED
MEDICITY NOTTINGHAM LIMITED
MEDILINK EAST MIDLANDS LIMITED
THE RENEWAL TRUST
THE UNITED KINGDOM SCIENCE PARK ASSOCIATION
TRANSDERMAL DIAGNOSTICS LTD
Laura Gow
BDD PHARMA LTD
DRUG DELIVERY INTERNATIONAL LIMITED
Joanne Kelley
1NHALER LTD
ALDERLEY PARK VENTURES LIMITED
BDD PHARMA LTD
DARA HOUSE CONSULTANCY LIMITED
DRUG DELIVERY INTERNATIONAL LIMITED
MICREGEN LTD
THE UNIVERSITY OF MANCHESTER INNOVATION CENTRE LIMITED
UNIVERSITY OF MANCHESTER INNOVATION FACTORY LIMITED
Claire Madden-Smith
BDD PHARMA LTD
DRUG DELIVERY INTERNATIONAL LIMITED
Howard Stevens
ACADEMY OF PHARMACEUTICAL SCIENCES
BDD PHARMA LTD
CATALENT U.K. SWINDON ZYDIS LIMITED
CRYSTALLOGRAFX LTD.
DRUG DELIVERY INTERNATIONAL LIMITED
SINAERX LTD
Carol Thomson
BDD PHARMA LTD
DRUG DELIVERY INTERNATIONAL LIMITED
Balance Sheet Unlock full report
Accounts Date 30-Nov-2024 30-Nov-2022 30-Nov-2021
Balance Sheet
Fixed Assets 18,000 18,000 18,000
Current Assets 2,818,199 2,818,199 2,834,854
Creditors Due Within One Year 139,948 139,948 116,450
Working Cap 2,678,251 2,678,251 2,718,404
Total Assets Less Current Liabilities 2,696,251 2,696,251 2,736,404
Long-term Liabilities 185,842 185,842 44,118
Net Assets 2,510,409 2,510,409 2,692,286
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 2,510,409 2,510,409 2,692,286
Common Size Financial Analysis Unlock full report
Accounts Date 30-Nov-2024 30-Nov-2022 30-Nov-2021
Tangible Fixed Assets - - -
Fixed Assets 0.6% 0.6% 0.6%
Stocks Inventory - - -
Debtors 98.6% 98.6% 99.4%
Cash Bank In Hand 0.8% 0.8% 0.0%
Current Assets 99.4% 99.4% 99.4%
Creditors Due Within One Year 4.9% 4.9% 4.1%
Net Current Assets Liabilities 94.4% 94.4% 95.3%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds 88.5% 88.5% 94.4%
Capital Employed - - -
Total Assets Less Current Liabilities 95.1% 95.1% 95.9%
Financial Ratio Analysis Unlock full report
Accounts Date 30-Nov-2024 30-Nov-2022 30-Nov-2021
Liquidity Ratio 20.1 20.1 24.3
Solvency Ratio 8.7 8.7 17.8
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 2
Mortgages Outstanding 1
Mortgages Part Satisfied 0
Mortgages Satisfied 1
Assets and Debt Analysis Unlock full report
Accounts Date 30-Nov-2024 30-Nov-2022 30-Nov-2021
Assets 2,836,199 2,836,199 2,852,854
Debt 325,790 325,790 160,568
Net Assets/Debt 2,510,409 2,510,409 2,692,286

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around G4 0SF
BDD PHARMA LTD
BIO IMAGING UNIT, BASEMENT MEDICAL BLOCK WITHIN GLASGOW ROYAL INFIRMARY, 84 CASTLE STREET, GLASGOW, G4 0SF
DRUG DELIVERY INTERNATIONAL LIMITED
BIO IMAGING UNIT, BASEMENT MEDICAL BLOCK WITHIN GLASGOW ROYAL INFIRMARY, 84 CASTLE STREET, GLASGOW, G4 0SF
Document Filings
Statement of capital following an allotment of shares on 9 February 2026
Confirmation statement made on 6 August 2025 with no updates
Registration of charge SC3832330002, created on 28 April 2025
Satisfaction of charge SC3832330001 in full
Confirmation statement made on 6 August 2024 with updates
Termination of appointment of Stephen Brown as a director on 31 December 2023
Confirmation statement made on 6 August 2023 with updates
Memorandum and Articles of Association
Resolutions
Statement of capital following an allotment of shares on 14 August 2023
Cancellation of shares. Statement of capital on 22 March 2023
Purchase of own shares.
Memorandum and Articles of Association
Resolutions
Appointment of Mrs Laura Gow as a director on 22 August 2022
Director's details changed for Dr Carol Christine Thomson on 17 November 2022
Director's details changed for Ms Joanne Kelley on 17 November 2022
Registered office address changed from C/O Bio Imaging Unit, Basement Medical Block Withiin Glasgow Royal Infirmary 84 Castle Street Glasgow G4 0SF to Bio Imaging Unit, Basement Medical Block within Glasgow Royal Infirmary 84 Castle Street Glasgow G4 0SF on 29 November 2022
Confirmation statement made on 6 August 2022 with no updates
Director's details changed for Dr Claire Elizabeth Madden-Smith on 24 August 2022
Appointment of Ms Claire Elizabeth Madden-Smith as a director on 1 May 2022
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free